US 12,220,423 B2
Compounds, derivatives, and analogs for cancer
Barbara Brooke Jennings, Juno Beach (FI)
Assigned to HYGIA PHARMACEUTICALS, LLC, Jupiter, FL (US)
Appl. No. 17/262,682
Filed by HYGIA PHARMACEUTICALS, LLC, Jupiter, FL (US)
PCT Filed Jul. 24, 2019, PCT No. PCT/US2019/043227
§ 371(c)(1), (2) Date Jan. 22, 2021,
PCT Pub. No. WO2020/023628, PCT Pub. Date Jan. 30, 2020.
Claims priority of provisional application 62/702,680, filed on Jul. 24, 2018.
Prior Publication US 2021/0353651 A1, Nov. 18, 2021
Int. Cl. A61K 31/683 (2006.01); A61K 31/265 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07C 69/96 (2006.01); C07F 9/117 (2006.01)
CPC A61K 31/683 (2013.01) [A61K 31/265 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07C 69/96 (2013.01); C07F 9/117 (2013.01); C07C 2601/14 (2017.05)] 13 Claims
OG exemplary drawing
 
1. A compound represented by the structure of formula XI,

OG Complex Work Unit Chemistry
or formula XII,

OG Complex Work Unit Chemistry
wherein n is an integer from 1-6.